Navaja, Baby Girl .

HRN: 28-31-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
AMPICILLIN 500MG (VIAL)
12/30/2025
01/06/2026
IV
145mg
Q12
PSNB (PROM X 15hrs)
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines